Trial Profile
A phase IIb trial of elamipretide for the treatment of intermediate dry age-related macular degeneration
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2018
Price :
$35
*
At a glance
- Drugs Elamipretide (Primary)
- Indications Dry age-related macular degeneration
- Focus Therapeutic Use
- 25 Jun 2018 New trial record